Inaugural Baptist Health Biomedical Research Symposium Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree

	5	4	3	2	1
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence Not applicable|Not applicable

	5	4	3	2	1	Not applicable
Recognize new therapies poised to impact the immediate future of patient care in our diverse communities.	Recognize new therapies poised to impact the immediate future of patient care in our diverse communities. - 5	Recognize new therapies poised to impact the immediate future of patient care in our diverse communities. - 4	Recognize new therapies poised to impact the immediate future of patient care in our diverse communities. - 3	Recognize new therapies poised to impact the immediate future of patient care in our diverse communities. - 2	Recognize new therapies poised to impact the immediate future of patient care in our diverse communities. - 1	Recognize new therapies poised to impact the immediate future of patient care in our diverse communities. - Not applicable
Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities.	Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities. - 5	Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities. - 4	Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities. - 3	Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities. - 2	Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities. - 1	Identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities. - Not applicable

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA= Not Applicable

	5	4	3	2	1	NA
The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer	The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer - 5	The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer - 4	The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer - 3	The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer - 2	The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer - 1	The Evolving Role of Decentralized Clinical Trials- Dr. Barbara E. Bierer - NA
Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne	Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne - 5	Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne - 4	Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne - 3	Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne - 2	Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne - 1	Innovations in Stem Cell Transplants and Immunotherapies- Dr. Guenther Koehne - NA
International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia	International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia - 5	International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia - 4	International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia - 3	International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia - 2	International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia - 1	International Radiosurgery Research Foundation Brain Metastases Clinical Trials Collaborative- Dr. Manmeet Ahluwalia - NA
Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante	Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante - 5	Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante - 4	Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante - 3	Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante - 2	Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante - 1	Clinical Trial in Acute Stroke (HEMERA 1) - Dr. Italo Linfante - NA
Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis	Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis - 5	Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis - 4	Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis - 3	Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis - 2	Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis - 1	Brain Tumor Drug Sensitivity and Implications for Therapy- Dr. Frank Vrionis - NA
Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer	Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer - 5	Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer - 4	Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer - 3	Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer - 2	Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer - 1	Vagal Nerve Stimulation for Rheumatoid Arthritis- Dr. Justin Sporrer - NA
A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia	A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia - 5	A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia - 4	A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia - 3	A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia - 2	A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia - 1	A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma- Dr. Yazmin Odia - NA
MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser	MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser - 5	MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser - 4	MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser - 3	MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser - 2	MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser - 1	MR-Guided Radiotherapy for Gastrointestinal Cancers- Dr. Adeel Kaiser - NA
Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman	Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman - 5	Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman - 4	Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman - 3	Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman - 2	Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman - 1	Insights From a Specialty Radiation Oncology Clinic and Moderated Discussion- Dr. Noah Kalman - NA
The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee	The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee - 5	The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee - 4	The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee - 3	The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee - 2	The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee - 1	The Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms- Dr. Woongchae A. Lee - NA
Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson	Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson - 5	Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson - 4	Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson - 3	Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson - 2	Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson - 1	Diagnostic and Treatment Strategies for Cardiovascular Calcification- Dr. Joshua D. Hutcheson - NA
Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas	Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas - 5	Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas - 4	Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas - 3	Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas - 2	Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas - 1	Vascular Histopathology on CKD Patients- Dr. Athanassios Tsoukas - NA
Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik	Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik - 5	Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik - 4	Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik - 3	Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik - 2	Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik - 1	Initiatives in Modern Orthopedic Care: OBERD- Dr. Gautam P. Yagnik - NA
Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez	Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez - 5	Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez - 4	Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez - 3	Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez - 2	Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez - 1	Emerging Technologies in Total Joint Arthroplasty- Dr. Juan Carlos Suarez - NA
State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac	State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac - 5	State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac - 4	State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac - 3	State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac - 2	State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac - 1	State of the Art in Total Shoulder Arthroplasty: Update From a Prospective 10 Year Follow-up Study- Dr. John Zvijac - NA
The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette	The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette - 5	The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette - 4	The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette - 3	The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette - 2	The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette - 1	The New Herbert Sling: Evolution From Benchtop to Bedside- Dr. Elizabeth Ann Ouellette - NA
360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins	360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins - 5	360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins - 4	360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins - 3	360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins - 2	360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins - 1	360-degree Surgical Management of Ankle Fractures: Minimally Invasive, Maximally Effective- Dr. Christopher Hodgkins - NA

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

As a result of my participation in this Symposium, I commit to make the following changes to my clinical practice: *

I will recognize new therapies poised to impact the immediate future of patient care in our diverse communities.

I will identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our communities.

Not applicable to my practice.

I do not agree with the recommendations presented.

I am retired.

What, if any, new skills/strategies will you apply in your clinical practice? *

What are the potential barriers or obstacles that might prevent you from implementing new strategies you learned at this activity? *

Comments

Name

Attestation *

Choose 1 option

I attest that I have participated in this live symposium in its entirety.

I attest that I have participated in _____ hours of instruction (max 5.75) during this symposium.

hours attestation *

Hours attended

Leave this field blank

You are here

Inaugural Baptist Health Biomedical Research Symposium Evaluation